Transferrin Saturation and Asthenia in Hemochromatosis
NCT03356548 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 260
Last updated 2019-07-31
Summary
Observational study.
Conditions
- Hemochromatoses, Genetic
Sponsors & Collaborators
-
Rennes University Hospital
lead OTHER
Principal Investigators
-
Fabrice LAINE · Rennes University Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-04-10
- Primary Completion
- 2019-04-09
- Completion
- 2019-04-09
Countries
- France
Study Locations
More Related Trials
-
HEPFER-Evaluation of a New Phenotypic Biological Marker in Genetic Type 1 Hemochromatosis
NCT01784939 ·Status: COMPLETED
-
Iron Status in BTM With Blood Transfusion
NCT04947540 ·Status: UNKNOWN
-
Detection Of β-thalassemia Carriers In Assiut
NCT03822585 ·Status: UNKNOWN ·Phase: NA
-
T2* in Transfusion Dependant Anemia, MI, LVF, Normal Patients
NCT00520559 ·Status: COMPLETED
-
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
NCT00000595 ·Status: COMPLETED ·Phase: PHASE2
-
Predisposing Factors for Liver Diseases in Patients With Chronic Hemolytic Anemia
NCT06743854 ·Status: NOT_YET_RECRUITING
-
Clinical Signs and Symptoms of Anemia in Patients Over 75 Years
NCT02662699 ·Status: UNKNOWN
-
Clinical and Laboratory Assessment of Iron Overload in Sickle Cell Anemia and Sickle Cell Thalassemia
NCT00512564 ·Status: COMPLETED
-
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198 ·Status: UNKNOWN
-
A Long-term Follow-up Study in Participants Who Received CS-101
NCT06685536 ·Status: ENROLLING_BY_INVITATION
-
Pharmacotherapy Prescribing Pattern and the Adherence Level to Iron Chelation Therapy in Thalassemia
NCT06210139 ·Status: COMPLETED
-
Treatment of Iron Deficiency Anaemia in Pregnancy Study
NCT03725150 ·Status: COMPLETED
-
Sexual Maturation in β-Thalassemia Major Patients in Assiut University Hospital
NCT03847558 ·Status: UNKNOWN
-
Efficacy and Safety of Efficacy and Safety of Continued Iron Chelation Therapy In Poly-transfused Thalassemia Patients With Low Serum Ferritin (< 500 ng/ml)
NCT01996683 ·Status: UNKNOWN ·Phase: NA
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Inhibiting Dietary Iron Absorption in Subjects With Hereditary Hemochromatosis by a Natural Polyphenol Supplement
NCT03990181 ·Status: COMPLETED ·Phase: NA
-
Study on the Effect of Different Risk Factors on the Growth Parameters of Thalassemic Patients in Assiut (AUCH)
NCT05303506 ·Status: UNKNOWN
-
Immunopathology of Autoimmune Hemolytic Anemia
NCT02158195 ·Status: COMPLETED
-
Rare Iron Overloads Except C282Y Homozygosity : Description and Characterization.
NCT01541813 ·Status: TERMINATED
-
Clinical Management of Hereditary Hemochromatosis: Phlebotomy vs. Erythrocytoapheresis
NCT00440986 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations
NCT01911871 ·Status: COMPLETED
-
Etiology of Anemia
NCT00302939 ·Status: TERMINATED
-
Erythrocytapheresis Versus Phlebotomy as Maintenance Therapy in Hereditary Hemochromatosis (HH) Patients
NCT01398644 ·Status: UNKNOWN ·Phase: PHASE3
-
Long-term Clinical Study of CN128 in Thalassemia With Sever Liver Iron Overloaded Patients
NCT05355766 ·Status: COMPLETED ·Phase: PHASE2
-
Study of the Prevalence of Iron Deficiency in Elderly Patient in Hospital Environment
NCT05514951 ·Status: COMPLETED ·Phase: NA